Table 2.
T2DN >48 wk Group |
|||||
---|---|---|---|---|---|
ANOVA |
Male |
Female |
|||
P Value | Mean | ± SE | Mean | ± SE | |
Potassium/Cre | 0.013 | 27.9 | ± 1.7 | 34.8 | ± 1.7 |
Sodium/Cre | 0.037 | 11 | ± 1 | 19 | ± 3 |
Calcium/Cre | NS | 0.16 | ± 0.02 | 0.17 | ± 0.06 |
Chloride/Cre | 0.001 | 20 | ± 3 | 35 | ± 2 |
Glucose/Cre | NS | 20 | ± 13 | 4 | ± 1 |
n ≥ 8 for each group; normality Test (Shapiro–Wilk); homogeneity of variance (Levene’s Test); ANOVA, Tukey post hoc P < 0.05. NS, nonsignificant values. Bold indicates significant difference between values. Cre, Creatinine; T2DN, Type 2 Diabetic Nephropathy.